60 Degrees Pharmaceuticals, Inc Common Stock
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $303 | $437 | $100 | $163 |
Gross Profit | 182 | -100 | 50 | 90 |
EBITDA | -1,895 | -2,292 | -1,712 | -1,858 |
EBIT | -1,835 | -2,315 | -1,732 | -1,875 |
Net Income | -1,441 | -2,317 | -1,733 | -1,876 |
Net Change In Cash | 303 | 437 | 100 | 163 |
Free Cash Flow | -4,707 | -2,119 | -1,497 | -1,602 |
Cash | 1,510 | 4,115 | 1,966 | 3,451 |
Basic Shares | 670 | 918 | 368 | 320 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $1,005 | $607 | $253 | $223 |
Gross Profit | 223 | 222 | -220 | -209 |
EBITDA | -7,758 | -7,883 | -1,426 | -2,109 |
EBIT | -7,947 | -1,526 | -2,187 | |
Net Income | -7,368 | -7,947 | -3,765 | -6,181 |
Net Change In Cash | 1,005 | 607 | 253 | 223 |
Free Cash Flow | -7,067 | -5,829 | -4,658 | -1,070 |
Cash | 1,510 | 1,659 | 2,142 | 264 |
Basic Shares | 670 | 113 | 990 | 1,445 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | -$8.17 |
2025-09-30 | -$0.67 |
2025-06-30 | -$1.26 |
2025-03-31 | -$1.55 |